Angewandte Chemie

Angewandte Chemie is a weekly peer-reviewed scientific journal that covers all aspects of chemistry. Its impact factor was 12.730 in 2010, the highest value for a chemistry-specific journal that publishes original research. It is a journal of the German Chemical Society and is published by Wiley-VCH. Besides original research in the form of short communications, the journal contains review-type articles (reviews, minireviews, essays, highlights), and a magazine section (news, obituaries, book reviews, conference reports). Colloquially, the journal is simply called "Angewandte". "Angewandte Chemie" is German for "applied chemistry", although this translation no longer accurately describes the scope of the journal.

Publisher
John Wiley & Sons Wiley-VCH
Country
Germany
History
1887-present (in German), 1962–present (in English)
Website
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-3773
Impact factor
12.730 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Big step in rapid diagnostics for infectious diseases

The speedy, high-tech method of inexpensive, accurate and high-throughput protein biomarker assay testing is being touted as a much-needed development in point-of-care (PoC) testing, say U.S. and Flinders University researchers ...

Oncology & Cancer

A cancer treatment with built-in light

Therapies should be highly effective and as free as possible of side effects—a big challenge, particularly in the case of cancer. A Chinese research team has now developed a novel form of photodynamic tumor therapy for ...

Oncology & Cancer

How to shut down the power stations of cancer cells

An emerging nanomedicine cancer treatment involving the injection of tiny nanoparticles carrying compounds that can poison cancerous cells has many benefits. This so-called photodynamic therapy (PDT) is non-toxic and it doesn't ...

Medical research

Research breakthrough in the fight against cancer

A team of researchers at the Center for Bioactive Delivery at the University of Massachusetts Amherst's Institute for Applied Life Sciences has engineered a nanoparticle that has the potential to revolutionize disease treatment, ...

Oncology & Cancer

Hand-held device reads levels of cancer biomarker

Researchers at McMaster and Brock universities have created the prototype for a hand-held device to measure a biomarker for cancer, paving the way for home-based cancer monitoring and to improve access to diagnostic testing.

page 1 from 3